Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples